CD34: structure, biology, and clinical utility.
Experimental Hematopoiesis Program, Johns Hopkins Oncology Center, Baltimore, MD, USA.
D S
DS
Krause
M J
MJ
Fackler
C I
CI
Civin
W S
WS
May
D000208:Acute Disease; D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D018952:Antigens, CD34 / Q000032:analysis / Q000737:chemistry / Q000502:physiology; D000951:Antigens, Neoplasm / Q000032:analysis; D015415:Biomarkers; D002448:Cell Adhesion; D004730:Endothelium, Vascular / Q000737:chemistry; D005347:Fibroblasts / Q000737:chemistry; D005786:Gene Expression Regulation; D005796:Genes; D006412:Hematopoietic Stem Cells / Q000737:chemistry; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology; D051379:Mice; D008969:Molecular Sequence Data; D009928:Organ Specificity; D011487:Protein Conformation; D012326:RNA Splicing
D000911:Antibodies, Monoclonal; D018952:Antigens, CD34; D000951:Antigens, Neoplasm; D015415:Biomarkers